290 related articles for article (PubMed ID: 30586268)
1. Navigating Targeted Therapeutics in Dermatology: Biologics and Small Molecules.
Costello C; Maarouf M; Shi V
J Drugs Dermatol; 2018 Dec; 17(12):1330-1332. PubMed ID: 30586268
[TBL] [Abstract][Full Text] [Related]
2. Biologics for chronic inflammatory skin diseases: an update for the clinician.
Yao Y; Ravn Jørgensen AH; Thomsen SF
J Dermatolog Treat; 2020 Mar; 31(2):108-130. PubMed ID: 30827126
[TBL] [Abstract][Full Text] [Related]
3. Beyond Psoriasis: Novel Uses for Biologic Response Modifiers in Pediatric Dermatology.
Bellodi-Schmidt F; Shah KN
Pediatr Dermatol; 2016; 33(1):18-27. PubMed ID: 26607958
[TBL] [Abstract][Full Text] [Related]
4. Non-psoriatic dermatologic uses of monoclonal antibody therapy.
Sockolov ME; Alikhan A; Zargari O
J Dermatolog Treat; 2009; 20(6):319-27. PubMed ID: 19954387
[TBL] [Abstract][Full Text] [Related]
5. A Practical Guide to Using Biologics in Pediatric Dermatology.
George A; Lansang RP; Lansang P; Gooderham M
J Cutan Med Surg; 2024; 28(1):59-67. PubMed ID: 38229411
[TBL] [Abstract][Full Text] [Related]
6. The Latest Drugs and Small Molecule Inhibitors for Skin and Hair.
Kalhan V; Sadick N
J Drugs Dermatol; 2017 Dec; 16(12):1224-1228. PubMed ID: 29240857
[TBL] [Abstract][Full Text] [Related]
7. An update on the topical and oral therapy options for treating pediatric atopic dermatitis.
Glines KR; Stiff KM; Freeze M; Cline A; Strowd LC; Feldman SR
Expert Opin Pharmacother; 2019 Apr; 20(5):621-629. PubMed ID: 30601075
[TBL] [Abstract][Full Text] [Related]
8. [Dermatologic treatment. The Danish Society of Dermatology].
Olesen AK; Jemec GB
Ugeskr Laeger; 2003 Mar; 165(12):1228. PubMed ID: 12701278
[No Abstract] [Full Text] [Related]
9. Pediatric dermatology-Critical approach to the new treatments.
Liang Y; Chen YL; Zhao MT; Wang ZY; Li L; Zhang B; Shen CP; Wang S; Xu ZG; Ma L
Dermatol Ther; 2019 Jul; 32(4):e12801. PubMed ID: 30537373
[TBL] [Abstract][Full Text] [Related]
10. Immunobiologicals in dermatology.
Silva DLFD; Secamilli EN; Beleli MV; Massuda JY; Franca AFEC; Magalhães RF
An Bras Dermatol; 2022; 97(3):275-283. PubMed ID: 35314083
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporine in Dermatology.
Kutlubay Z; Erdogan BÇ; Engin B; Serdaroglu S
Skinmed; 2016; 14(2):105-9. PubMed ID: 27319953
[TBL] [Abstract][Full Text] [Related]
12. Biologics in dermatology: What does the future hold?
Yavuz C
Dermatol Ther; 2019 Jul; 32(4):e12932. PubMed ID: 30977240
[TBL] [Abstract][Full Text] [Related]
13. Impact of the COVID-19 pandemic on the course and management of chronic inflammatory immune-mediated skin diseases: What's the evidence?
Patsatsi A; Kyriakou A
Clin Dermatol; 2021; 39(1):52-55. PubMed ID: 33972053
[TBL] [Abstract][Full Text] [Related]
14. Update on TNF Inhibitors in Dermatology.
Sobell JM
Semin Cutan Med Surg; 2016 Jun; 35(6 Suppl):S104-6. PubMed ID: 27537073
[TBL] [Abstract][Full Text] [Related]
15. Biologics and Small Molecule Agents in Allergic and Immunologic Skin Diseases.
Kaufman BP; Alexis AF
Curr Allergy Asthma Rep; 2018 Aug; 18(10):55. PubMed ID: 30171358
[TBL] [Abstract][Full Text] [Related]
16. [Biological dermatologic agents. The Danish Society of Dermatology].
Iversen L; Kragballe K;
Ugeskr Laeger; 2007 Mar; 169(12):1100. PubMed ID: 17394811
[No Abstract] [Full Text] [Related]
17. [What's New in Dermatological Therapy?].
Bachelez H
Ann Dermatol Venereol; 2015 Dec; 142 Suppl 3():S49-54. PubMed ID: 26792414
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Synergy, Neutrality, and Antagonism: Combination Treatment in Dermatology.
Strom MA; Mohan GC; Lio PA
J Drugs Dermatol; 2016 Oct; 15(10):1203-1207. PubMed ID: 27741337
[TBL] [Abstract][Full Text] [Related]
19. Targeting dysbiosis in psoriasis, atopic dermatitis, and hidradenitis suppurativa: the gut-skin axis and microbiome-directed therapy.
Aguwa C; Enwereji N; Santiago S; Hine A; Kels GG; McGee J; Lu J
Clin Dermatol; 2023; 41(5):640-649. PubMed ID: 37816413
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy of topical antipsoriatic treatments, systemic treatment and biologics: is severity assessment beyond Psoriasis Area and Severity Index a necessity?
van de Kerkhof PC; Mrowietz U; Segaert S; Kragballe K
Br J Dermatol; 2007 Apr; 156(4):771-2. PubMed ID: 17263798
[No Abstract] [Full Text] [Related]
[Next] [New Search]
